Fresenius SE & Co. KGaA
Provides products and services for the care of critically and chronically ill patients.
FRE | F
Overview
Corporate Details
- ISIN(s):
- CH1298665980 (+4 more)
- LEI:
- XDFJ0CYCOO1FXRFTQS51
- Country:
- Germany
- Address:
- Else-Kröner-Straße 1, 61352 Bad Homburg vor der Höhe
- Website:
- https://www.fresenius.com/
- Industry:
- Hospital activities
Description
Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-25 11:14 | English | 22.2 KB | |||
| 2023-04-25 08:59 | English | 22.2 KB | |||
| 2023-04-18 18:15 | English | 22.2 KB | |||
| 2023-04-03 10:05 |
Fresenius SE & Co. KGaA: Sara Hennicken, buy
|
English | 9.5 KB | ||
| 2023-04-03 10:00 |
Fresenius SE & Co. KGaA: Michael Sen, buy
|
English | 9.5 KB | ||
| 2023-03-24 00:00 |
Annual financial report 2022
|
English | 10.9 MB | ||
| 2023-03-23 00:00 |
Corporate Governance Declaration and Report 2022 of Fresenius SE & Co. KGaA
|
English | 138.5 KB | ||
| 2023-03-21 14:19 | English | 22.2 KB | |||
| 2023-03-15 00:00 |
Barclays – Global Healthcare Conference
|
English | 2.0 MB | ||
| 2023-03-01 00:00 |
Credit Suisse Global Healthcare Conference
|
English | 2.0 MB | ||
| 2023-03-01 00:00 |
Erklärung zur Unternehmensführung und Corporate Governance Bericht 2022 der Fre…
|
German | 145.5 KB | ||
| 2023-02-28 00:00 |
Morgan Stanley, European MedTech & Services Conference
|
English | 2.0 MB | ||
| 2023-02-22 00:00 |
Conference Call FY 2022, Fresenius
|
English | 2.1 MB | ||
| 2023-02-21 19:02 |
Fresenius SE & Co. KGaA: Outlook 2023 Fresenius advances with deconsolidation …
|
English | 7.3 KB | ||
| 2023-02-09 16:24 |
Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolida…
|
English | 6.3 KB |
Automate Your Workflow. Get a real-time feed of all Fresenius SE & Co. KGaA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fresenius SE & Co. KGaA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fresenius SE & Co. KGaA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-04 | Moser, Dr. Michael | Board | Buy | None | 300,565.98 EUR |
| 2023-04-03 | Sen, Michael | Board | Buy | None | 586,989.25 EUR |
| 2023-04-03 | Hennicken, Sara | Board | Buy | None | 49,839.92 EUR |
| 2022-11-18 | De Meo, Dr. Francesco | Board | Buy | None | 50,415.29 EUR |
| 2022-08-29 | De Meo, Dr. Francesco | Board | Sell | None | 50,831.20 EUR |
| 2022-08-05 | Sturm, Stephan | Board | Buy | None | 119,831.44 EUR |
| 2022-08-05 | Sturm, Stephan | Board | Buy | None | 119,676.59 EUR |
| 2022-08-05 | Schmitt, Martin | Board | Buy | None | 5,150.00 EUR |
| 2022-06-10 | Sturm, Stephan | Board | Other | None | 54,089.64 EUR |
| 2022-06-10 | Kirsch, Wolfgang | Supervisory board | Other | None | 6,901.09 EUR |
Peer Companies
